Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Blakemore

Showing results (291-300 of 300) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 300 results.
The Journal of Bone and Joint Surgery. American Volume|August 22, 2014
Development and initial validation of the Classification of Early-Onset Scoliosis (C-EOS)Brendan A Williams, Hiroko Matsumoto, Daren J McCalla, et al.
Journal of Medicinal Chemistry|April 20, 2018
Discovery of Allosteric, Potent, Subtype Selective, and Peripherally Restricted TrkA Kinase InhibitorsSharan K Bagal, Kiyoyuki Omoto, David C Blakemore, et al.
The Journal of Bone and Joint Surgery. American Volume|May 17, 2013
Evaluating the extent of clinical uncertainty among treatment options for patients with early-onset scoliosisJacqueline Corona, Daniel J Miller, Jenny Downs, et al.
The Journal of Bone and Joint Surgery. American Volume|November 16, 2023
The Effect of Implant Density on Adolescent Idiopathic Scoliosis Fusion: Results of the Minimize Implants Maximize Outcomes Randomized Clinical TrialA Noelle Larson, David W Polly, Paul D Sponseller, et al.
Chemmedchem|April 15, 2014
The discovery of potent nonstructural protein 5A (NS5A) inhibitors with a unique resistance profile-Part 2Florian Wakenhut, Thien Duc Tran, Chris Pickford, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2017
Highly potent and selective Na<sub>V</sub>1.7 inhibitors for use as intravenous agents and chemical probesR Ian Storer, Andy Pike, Nigel A Swain, et al.
Journal of Medicinal Chemistry|June 27, 2018
Discovery of Potent, Selective, and Peripherally Restricted Pan-Trk Kinase Inhibitors for the Treatment of PainSharan K Bagal, Mark Andrews, Bruce M Bechle, et al.
Spine|June 10, 2024
Development of Consensus-Based Best Practice Guidelines for the Perioperative and Postoperative Care of Pediatric Patients With Spinal Deformity and Programmable Implanted DevicesWalter H Truong, Hiroko Matsumoto, Jaysson T Brooks, et al.
Journal of Medicinal Chemistry|September 22, 2025
Discovery of PF-07054894, a Potent Squaramide-Based CCR6 Antagonist Displaying High CXCR2 SelectivityMark E Schnute, Huixian Wu, John I Trujillo, et al.
ACS Medicinal Chemistry Letters|August 20, 2025
Peptidylarginine Deiminase (PAD) Inhibitor Optimization through Displacement of a Trapped Water MoleculeMark E Schnute, Gary M Chinigo, Kentaro Futatsugi, et al.
Pageof 30

Showing results (291-300 of 300) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 300 results.
The Journal of Bone and Joint Surgery. American Volume|August 22, 2014
Development and initial validation of the Classification of Early-Onset Scoliosis (C-EOS)Brendan A Williams, Hiroko Matsumoto, Daren J McCalla, et al.
Journal of Medicinal Chemistry|April 20, 2018
Discovery of Allosteric, Potent, Subtype Selective, and Peripherally Restricted TrkA Kinase InhibitorsSharan K Bagal, Kiyoyuki Omoto, David C Blakemore, et al.
The Journal of Bone and Joint Surgery. American Volume|May 17, 2013
Evaluating the extent of clinical uncertainty among treatment options for patients with early-onset scoliosisJacqueline Corona, Daniel J Miller, Jenny Downs, et al.
The Journal of Bone and Joint Surgery. American Volume|November 16, 2023
The Effect of Implant Density on Adolescent Idiopathic Scoliosis Fusion: Results of the Minimize Implants Maximize Outcomes Randomized Clinical TrialA Noelle Larson, David W Polly, Paul D Sponseller, et al.
Chemmedchem|April 15, 2014
The discovery of potent nonstructural protein 5A (NS5A) inhibitors with a unique resistance profile-Part 2Florian Wakenhut, Thien Duc Tran, Chris Pickford, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2017
Highly potent and selective Na<sub>V</sub>1.7 inhibitors for use as intravenous agents and chemical probesR Ian Storer, Andy Pike, Nigel A Swain, et al.
Journal of Medicinal Chemistry|June 27, 2018
Discovery of Potent, Selective, and Peripherally Restricted Pan-Trk Kinase Inhibitors for the Treatment of PainSharan K Bagal, Mark Andrews, Bruce M Bechle, et al.
Spine|June 10, 2024
Development of Consensus-Based Best Practice Guidelines for the Perioperative and Postoperative Care of Pediatric Patients With Spinal Deformity and Programmable Implanted DevicesWalter H Truong, Hiroko Matsumoto, Jaysson T Brooks, et al.
Journal of Medicinal Chemistry|September 22, 2025
Discovery of PF-07054894, a Potent Squaramide-Based CCR6 Antagonist Displaying High CXCR2 SelectivityMark E Schnute, Huixian Wu, John I Trujillo, et al.
ACS Medicinal Chemistry Letters|August 20, 2025
Peptidylarginine Deiminase (PAD) Inhibitor Optimization through Displacement of a Trapped Water MoleculeMark E Schnute, Gary M Chinigo, Kentaro Futatsugi, et al.
Pageof 30